GSK3B and hepatocellular carcinoma: Yet other mechanisms that mediate the activity of NDRG1 have been reported examining Huh7 and HepG2 hepatocellular carcinoma cells, where direct binding of NDRG1 to GSK-3β prevented its binding to β-catenin (90).